Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
General Research Article

N-unsubstituted Imidazoles: Design, Synthesis, and Antimicrobial Evaluation

Author(s): Asghar Davood*, Yassamin EbrahimiNassimi, Soroush Sardari and Yekta Farmahini Farahani

Volume 29, Issue 23, 2023

Published on: 09 August, 2023

Page: [1875 - 1881] Pages: 7

DOI: 10.2174/1381612829666230807120704

Price: $65

conference banner
Abstract

Background: All the current antifungal azoles have one substituted nitrogen atom in their imidazole or triazole rings. In this study, eleven imine and amine derivatives of imidazole, in which both nitrogen atoms of the imidazole ring are unsubstituted, were designed and synthesized.

Materials and Methods: Imine derivatives were prepared by condensation of imidazole-4-carboxaldehyde with appropriate amines, and then in the next step, using sodium borohydride, the imines were reduced to amine derivatives. Docking studies reveal unsubstituted nitrogen atom of the imidazole ring coordinated well with the heme molecule of the receptor. In vitro, antimicrobial evaluation was tested on Candida albicans, E. coli, and Staphylococcus aureus.

Results: Based on the results of the antimicrobial study, compound 10, which contains 4-chlorobenzyl moiety, proved to be the most potent compound against Candida albicans, and it was more active than the reference drug fluconazole and showed comparable activity to amphotericin B. Compounds 10 and 11 and compounds 8, 10 and 11 showed significant responses against E. coli and Staphylococcus aureus respectively.

Conclusion: It is concluded that compound 10 can be acted as a new lead compound to find new azoles antifungal.

Erratum In:
N-unsubstituted Imidazoles: Design, Synthesis, and Antimicrobial Evaluation

« Previous
[1]
Chowdhary A, Tarai B, Singh A, Sharma A. Multidrug-Resistant Candida auris Infections in Critically Ill Coronavirus Disease Patients, India, April–July 2020. Emerg Infect Dis 2020; 26(11): 2694-6.
[http://dx.doi.org/10.3201/eid2611.203504] [PMID: 32852265]
[2]
Bouz G, Doležal M. Advances in antifungal drug development: An up-to-date mini review. Pharmaceuticals 2021; 14(12): 1312-33.
[http://dx.doi.org/10.3390/ph14121312] [PMID: 34959712]
[3]
Boral H, Metin B, Döğen A, Seyedmousavi S, Ilkit M. Overview of selected virulence attributes in Aspergillus fumigatus, Candida albicans, Cryptococcus neoformans, Trichophyton rubrum, and Exophiala dermatitidis. Fungal Genet Biol 2018; 111: 92-107.
[http://dx.doi.org/10.1016/j.fgb.2017.10.008] [PMID: 29102684]
[4]
Du H, Bing J, Hu T, Ennis CL, Nobile CJ, Huang G. Candida auris: Epidemiology, biology, antifungal resistance, and virulence. PLoS Pathog 2020; 16(10): e1008921.
[http://dx.doi.org/10.1371/journal.ppat.1008921] [PMID: 33091071]
[5]
McEvoy K, Normile TG, Poeta MD. Antifungal drug development: Targeting the fungal sphingolipid pathway. J Fungi 2020; 6(3): 142.
[http://dx.doi.org/10.3390/jof6030142] [PMID: 32825250]
[6]
Liu W, Yuan L, Wang S. Recent progress in the discovery of antifungal agents targeting the cell wall. J Med Chem 2020; 63(21): 12429-59.
[http://dx.doi.org/10.1021/acs.jmedchem.0c00748] [PMID: 32692166]
[7]
Sheehan DJ, Hitchcock CA, Sibley CM. Current and emerging azole antifungal agents. Clin Microbiol Rev 1999; 12(1): 40-79.
[http://dx.doi.org/10.1128/CMR.12.1.40] [PMID: 9880474]
[8]
Hoekstra WJ, Garvey EP, Moore WR, Rafferty SW, Yates CM, Schotzinger RJ. Design and optimization of highly-selective fungal CYP51 inhibitors. Bioorg Med Chem Lett 2014; 24(15): 3455-8.
[http://dx.doi.org/10.1016/j.bmcl.2014.05.068] [PMID: 24948565]
[9]
Sadeghpour H, Ghasemi Y, Rezaie Z, Khabnadideh S. FalahZadeh. Z Iran J Pharm Sci 2012; 8: 267-70.
[10]
Davood A, Alipour E, Shafiee A. Efficient synthesis of imidazole derivatives: An important synthons for preparing biologically active compounds. Turk J Chem 2008; 32: 389-95.
[11]
Iman M, Davood A. Homology modeling of lanosterol 14α-demethylase of Candida albicans and insights into azole binding. Med Chem Res 2014; 23(6): 2890-9.
[http://dx.doi.org/10.1007/s00044-013-0769-z]
[12]
Iman M, Davood A, Gebbink BK, Azerang P, Alibolandi M, Sardari S. Design and antimicrobial evaluation of 1-methylimidazole derivatives as new antifungal and antibacterial agents. Pharm Chem J 2014; 48(8): 513-9.
[http://dx.doi.org/10.1007/s11094-014-1140-5]
[13]
Davood A. Design, synthesis and antimicrobial evaluation of new azoles: A molecular hybridization approach. Pharm Chem J 2016; 49(10): 687-93.
[http://dx.doi.org/10.1007/s11094-016-1354-9]
[14]
Davood A, Rahimi A, Iman M, Azerang P, Sardari S, Mahboubi A. Design and synthesis of new antifungals based on N-un-substituted azoles as 14α demethylase inhibitor. Curr Computeraided Drug Des 2021; 17(2): 235-43.
[http://dx.doi.org/10.2174/1573409916666200217090855] [PMID: 32065093]
[15]
Olszewski T, Boduszek B. Application of Bis(trimethylsilyl) phosphonite in the efficient preparation of new heterocyclic α-aminomethyl-H-phosphinic acids. Synthesis 2011; 2011(3): 437-42.
[http://dx.doi.org/10.1055/s-0030-1258387]
[16]
Gerz I, Jannuzzi SAV, Hylland KT, et al. Structural elucidation, aggregation, and dynamic behaviour of n,n,n,ncopper(i) schiff base complexes in solid and in solution: A Combined NMR, X-ray spectroscopic and crystallographic investigation. Eur J Inorg Chem 2021; 46: 4762-75.
[17]
Zhu XW, Zhuang FL, Chen ZY, et al. Heterometal-organic cages as photo-fenton-like catalysts. Inorg Chem 2021; 60(19): 14721-30.
[http://dx.doi.org/10.1021/acs.inorgchem.1c01841] [PMID: 34520203]
[18]
Davood A, Iman M. Molecular docking and QSAR study on imidazole derivatives as 14α-demethylase inhibitors. Turk J Chem 2013; 37: 119-33.
[19]
Davood A, Iman M. In silico studies on triazole derivatives as antifungal agents. JHPSH 2014; 1(3): 57-63.
[20]
Davood A, Asnaashari B, Iman M. Docking and QSAR studies of triazole derivatives as more potent and effective antifungal agents. J Mil Med 2015; 17(2): 100-5.
[21]
Huey R, Morris GM. Using Autodock 4 with Autodocktools: A tutorial. California: The Scripps Research Institute 2008; pp. 54-6.
[22]
Morris GM, Huey R, Lindstrom W, et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 2009; 30(16): 2785-91.
[http://dx.doi.org/10.1002/jcc.21256] [PMID: 19399780]
[23]
Wallace AC, Laskowski RA, Thornton JM. LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions. Protein Eng Des Sel 1995; 8(2): 127-34.
[http://dx.doi.org/10.1093/protein/8.2.127] [PMID: 7630882]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy